Level 1 - Absolute Beginner
Some molecules have two forms. They look like your left hand and your right hand. They are mirror images.
The two forms can act very differently in the body. One form can be a good medicine. The other form may not help at all.
Two scientists won the Nobel Prize in Chemistry on October 7. They are Henri Kagan from France and Kenso Soai from Japan.
Their work helps scientists make just one form of a molecule. This is important for making safe medicines.
- molecule
- A very small group of atoms joined together.
- mirror image
- A reflection that is the same shape but reversed.
- medicine
- Something you take to treat an illness.
- scientist
- A person who studies how the world works.
- prize
- An award for doing something very well.
- chemistry
- The science of substances and how they change.
- form
- A kind or version of something.
- safe
- Not likely to cause harm.
Level 2 - Elementary
The 2026 Nobel Prize in Chemistry was announced on October 7. It goes to Henri Kagan of France and Kenso Soai of Japan. Mr. Kagan is 95 years old.
Many molecules come in two mirror-image forms, like a left hand and a right hand. Living things usually use only one form. A medicine can work well in one form and be useless or even harmful in the other.
The prize is for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis. This means they found new ways that small differences between the two forms can grow.
Mr. Soai found a reaction in which the product helps make more of itself. A tiny extra amount of one form grows into a large amount. This may help explain why life uses only one form.
- announce
- To tell the public something officially.
- living things
- Plants, animals and other forms of life.
- harmful
- Causing damage or illness.
- discovery
- Finding something for the first time.
- reaction
- A chemical change when substances mix.
- product
- What is made at the end of a chemical reaction.
- explain
- To make something clear.
- tiny
- Extremely small.
Level 3 - Intermediate
The 2026 Nobel Prize in Chemistry has been awarded to Henri Kagan of France, who is 95, and Kenso Soai of Japan. The Royal Swedish Academy of Sciences honored them for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.
The problem they tackled is chirality. Many molecules exist as two mirror-image versions, called enantiomers, that are chemically similar but can behave very differently in living bodies. This matters most for pharmaceuticals, where one version may heal and the other may be inactive or harmful.
Mr. Kagan showed that the result of a reaction does not always rise in proportion to the purity of the catalyst, a surprising non-linear effect. Mr. Soai, working at the Tokyo University of Science, discovered in 1995 a reaction in which a molecule acts as a catalyst for making more of itself.
In his reaction, a very small initial excess of one mirror-image form, about two percent in early experiments, was amplified to a large majority. The finding gives chemists a possible explanation for how life's one-handedness began and a toolkit for producing single-form drugs.
- chirality
- The property of a molecule that is not identical to its mirror image.
- enantiomers
- The two mirror-image forms of a chiral molecule.
- pharmaceuticals
- Medicines made and sold as drugs.
- catalyst
- A substance that speeds up a reaction without being used up.
- purity
- The degree to which something is free of other things.
- excess
- An amount that is more than another amount.
- amplified
- Made larger or stronger.
- toolkit
- A set of methods for a task.
Level 4 - Advanced
The Nobel Prize in Chemistry for 2026 has gone to Henri Kagan, 95, of France and Kenso Soai of Japan, for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis. The citation honors two ideas that reshaped how chemists think about handedness at the molecular scale.
Chirality is the underlying puzzle. Many molecules exist as non-superimposable mirror images, or enantiomers, that share most physical properties yet interact differently with the chiral machinery of living cells. In pharmaceuticals the distinction is decisive: one enantiomer can be a therapy while its twin is inert or toxic, which is why producing a single form has long been a central goal of synthesis.
Mr. Kagan's non-linear effects overturned an intuitive assumption, namely that the enantiomeric purity of a product tracks that of the catalyst in a straight line. Mr. Soai, based at the Tokyo University of Science, went further in 1995 with asymmetric autocatalysis: a chiral product that catalyzes its own formation, so that a minuscule imbalance, a few percent in early experiments, is magnified toward near-complete dominance of one hand.
The implications reach beyond the flask. Because the reaction can amplify an almost random fluctuation, it offers a plausible mechanism for how prebiotic chemistry might have broken the symmetry that left life with left-handed amino acids and right-handed sugars. It remains a model rather than proof of origins, but it is the most compelling laboratory demonstration of the principle.
- citation
- A formal statement explaining why an award is given.
- non-superimposable
- Unable to be placed exactly on top of its mirror image.
- inert
- Not chemically active.
- autocatalysis
- A reaction in which a product speeds up its own formation.
- minuscule
- Extremely small.
- magnified
- Made much greater.
- prebiotic
- Existing before life began.
- symmetry
- Balanced similarity of parts on either side.
Talk about this article with KatePractice this story's vocabulary in a real spoken conversation with your AI tutor